Your browser is no longer supported. Please, upgrade your browser.
Settings
GSK [NYSE]
GlaxoSmithKline plc
Index- P/E13.96 EPS (ttm)2.88 Insider Own0.20% Shs Outstand2.50B Perf Week1.59%
Market Cap98.79B Forward P/E13.12 EPS next Y3.06 Insider Trans0.00% Shs Float2.49B Perf Month0.80%
Income7.24B PEG3.17 EPS next Q0.51 Inst Own12.60% Short Float0.61% Perf Quarter7.50%
Sales44.63B P/S2.21 EPS this Y23.20% Inst Trans0.14% Short Ratio3.54 Perf Half Y7.76%
Book/sh8.19 P/B4.90 EPS next Y14.61% ROA6.50% Target Price49.17 Perf Year-0.27%
Cash/sh2.69 P/C14.90 EPS next 5Y4.40% ROE36.70% 52W Range33.26 - 42.40 Perf YTD9.08%
Dividend2.17 P/FCF27.66 EPS past 5Y-7.90% ROI17.30% 52W High-5.33% Beta0.69
Dividend %5.41% Quick Ratio0.60 Sales past 5Y7.30% Gross Margin67.60% 52W Low20.69% ATR0.50
Employees94066 Current Ratio0.90 Sales Q/Q-18.40% Oper. Margin23.00% RSI (14)56.12 Volatility1.16% 0.99%
OptionableYes Debt/Eq1.76 EPS Q/Q-31.80% Profit Margin16.20% Rel Volume0.84 Prev Close40.10
ShortableYes LT Debt/Eq1.55 EarningsJul 28 BMO Payout55.10% Avg Volume4.31M Price40.14
Recom2.00 SMA200.80% SMA501.43% SMA2007.23% Volume3,624,332 Change0.10%
Jun-24-21Upgrade Deutsche Bank Sell → Hold
Mar-23-21Downgrade SVB Leerink Outperform → Mkt Perform
Feb-04-21Downgrade Deutsche Bank Hold → Sell
Jan-20-21Downgrade Credit Suisse Neutral → Underperform
Jan-15-21Initiated Deutsche Bank Hold
Nov-02-20Upgrade Liberum Hold → Buy
Sep-29-20Initiated Berenberg Buy
Feb-12-20Downgrade Shore Capital Hold → Sell
Jan-16-20Downgrade Barclays Equal Weight → Underweight
Dec-02-19Initiated SVB Leerink Outperform
Nov-21-19Upgrade UBS Neutral → Buy
Oct-11-19Upgrade Cantor Fitzgerald Hold → Buy
Sep-03-19Upgrade Societe Generale Sell → Buy
Sep-03-19Resumed Citigroup Neutral
Aug-13-19Resumed JP Morgan Neutral
Jun-17-19Resumed Morgan Stanley Underweight
Mar-08-19Downgrade Shore Capital Buy → Hold
Feb-22-19Downgrade UBS Buy → Neutral
Jan-14-19Downgrade Exane BNP Paribas Outperform → Neutral
Dec-11-18Resumed Jefferies Buy
Jul-30-21 08:57PM  
01:56PM  
11:28AM  
10:12AM  
07:51AM  
Jul-29-21 06:03PM  
02:06PM  
12:58PM  
11:03AM  
Jul-28-21 06:00PM  
01:51PM  
11:07AM  
09:11AM  
08:51AM  
08:28AM  
07:25AM  
07:09AM  
06:47AM  
06:20AM  
03:36AM  
Jul-27-21 02:12PM  
11:14AM  
Jul-26-21 03:59PM  
09:38AM  
Jul-23-21 01:53PM  
10:15AM  
08:01AM  
Jul-22-21 02:36PM  
Jul-21-21 08:00PM  
01:43PM  
Jul-20-21 02:51PM  
Jul-19-21 02:01PM  
Jul-16-21 01:37PM  
10:59AM  
09:48AM  
08:12AM  
02:33AM  
Jul-15-21 08:00PM  
02:58PM  
Jul-14-21 01:49PM  
12:57PM  
Jul-13-21 01:22PM  
12:53PM  
Jul-12-21 03:09PM  
Jul-10-21 07:00AM  
Jul-09-21 02:22PM  
08:10AM  
08:01AM  
Jul-08-21 01:57PM  
09:19AM  
Jul-07-21 01:46PM  
12:56PM  
08:55AM  
04:58AM  
Jul-06-21 07:01PM  
05:49PM  
04:47PM  
02:21PM  
06:27AM  
Jul-05-21 10:14AM  
Jul-02-21 02:54PM  
01:39PM  
01:38PM  
12:22PM  
11:49AM  
11:09AM  
10:41AM  
10:07AM  
08:15AM  
08:04AM  
07:38AM  
07:34AM  
07:30AM  
07:01AM  
06:34AM  
06:09AM  
Jul-01-21 08:00PM  
03:05PM  
01:19PM  
09:44AM  
07:57AM  
06:10AM  
05:52AM  
03:59AM  
03:52AM  
03:49AM  
03:44AM  
02:15AM  
Jun-30-21 08:00PM  
08:00PM  
02:20PM  
Jun-29-21 02:42PM  
01:04PM  
07:18AM  
04:10AM  
Jun-28-21 02:09PM  
01:30AM  
Jun-25-21 01:45PM  
Jun-24-21 02:00PM  
10:57AM  
GlaxoSmithKline plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Lyell Immunopharma, Inc.; Novartis; Sanofi SA; Surface Oncology; Progentec Diagnostics, Inc.; Alector, Inc.; and CureVac AG., as well as strategic partnership with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GLAXOSMITHKLINE PLC10% OwnerJul 02Buy18.00275,0004,950,0001,007,583Jul 06 04:38 PM
GLAXOSMITHKLINE PLC10% OwnerMay 20Sale12.2532,005,260392,064,4350May 24 05:04 PM